Michael Grey Joins Pappas Ventures
Michael Grey has been named a venture partners with Pappas Ventures. Grey has served as a member of the firm's scientific advisory board for the past six years, and has served as CEO of Auspex Pharmaceuticals, SGX Pharmaceuticals (acquired by Eli Lilly) and Trega Biosciences (acquired by Lion Bioscience).
11 January 2010•2 mins read
